IL100163A0 - Polypeptides,useful as plasminogen activators,plasmids coding therefor and their manufacture - Google Patents

Polypeptides,useful as plasminogen activators,plasmids coding therefor and their manufacture

Info

Publication number
IL100163A0
IL100163A0 IL100163A IL10016391A IL100163A0 IL 100163 A0 IL100163 A0 IL 100163A0 IL 100163 A IL100163 A IL 100163A IL 10016391 A IL10016391 A IL 10016391A IL 100163 A0 IL100163 A0 IL 100163A0
Authority
IL
Israel
Prior art keywords
plasminogen activators
polypeptides
manufacture
useful
coding therefor
Prior art date
Application number
IL100163A
Other languages
English (en)
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of IL100163A0 publication Critical patent/IL100163A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
IL100163A 1991-01-22 1991-11-27 Polypeptides,useful as plasminogen activators,plasmids coding therefor and their manufacture IL100163A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4101736A DE4101736A1 (de) 1991-01-22 1991-01-22 Neue als plasminogenaktivatoren einsetzbare polypeptide, dafuer codierende plasmide und verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
IL100163A0 true IL100163A0 (en) 1992-08-18

Family

ID=6423453

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100163A IL100163A0 (en) 1991-01-22 1991-11-27 Polypeptides,useful as plasminogen activators,plasmids coding therefor and their manufacture

Country Status (15)

Country Link
EP (1) EP0496327B1 (ja)
JP (1) JPH06169770A (ja)
AT (1) ATE204326T1 (ja)
DE (2) DE4101736A1 (ja)
DK (1) DK0496327T3 (ja)
ES (1) ES2164048T3 (ja)
FI (1) FI920263A (ja)
HK (1) HK1010108A1 (ja)
HU (1) HU212510B (ja)
IE (1) IE914040A1 (ja)
IL (1) IL100163A0 (ja)
LT (1) LT3948B (ja)
LV (1) LV10974A (ja)
PT (1) PT496327E (ja)
RU (1) RU2108387C1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6017877A (en) * 1990-04-06 2000-01-25 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
KR100225511B1 (ko) * 1994-12-30 1999-10-15 성재갑 소 성장호르몬의 대량 생산 방법
JP2003521222A (ja) * 1998-03-06 2003-07-15 アボット・ラボラトリーズ 高度結晶性ウロキナーゼ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78180B (ja) * 1982-04-15 1984-09-26 Genentech Inc
NL8601240A (nl) 1986-05-15 1987-12-01 Leuven Res & Dev Vzw Plasminogeenactivator en trombolytisch geneesmiddel.
EP0316068A1 (en) * 1987-10-09 1989-05-17 Collaborative Research Inc. Modified low molecular weight plasminogen activator and method of preparation
DE3735917A1 (de) * 1987-10-23 1989-05-03 Basf Ag Neue polypeptide, ihre herstellung und verwendung
DE3810474A1 (de) * 1988-03-26 1989-10-05 Boehringer Ingelheim Int Expressionsvektoren
GB8809093D0 (en) * 1988-04-18 1988-05-18 Erba Carlo Spa Low molecular weight derivatives of prourokinase
AU5515790A (en) * 1989-05-18 1990-11-22 Green Cross Corporation, The Human prourokinase variants, methods of producing same, dna sequences, plasmids and hosts therefor
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator

Also Published As

Publication number Publication date
LT3948B (en) 1996-05-27
HU212510B (en) 1996-07-29
FI920263A (fi) 1992-07-23
DK0496327T3 (da) 2001-12-03
HUT63877A (en) 1993-10-28
LV10974A (lv) 1995-12-20
IE914040A1 (en) 1992-07-29
LTIP1532A (en) 1995-06-26
FI920263A0 (fi) 1992-01-21
PT496327E (pt) 2002-02-28
EP0496327A1 (de) 1992-07-29
HK1010108A1 (en) 1999-06-11
DE59209915D1 (de) 2001-09-20
EP0496327B1 (de) 2001-08-16
JPH06169770A (ja) 1994-06-21
HU9200127D0 (en) 1992-04-28
ES2164048T3 (es) 2002-02-16
RU2108387C1 (ru) 1998-04-10
DE4101736A1 (de) 1992-07-23
ATE204326T1 (de) 2001-09-15

Similar Documents

Publication Publication Date Title
CA2168429A1 (en) Expression of fusion polypeptides transported out of cytoplasm without leader sequences
ES8602361A1 (es) Procedimiento para preparar una composicion pulverulenta para bebida
DK161097C (da) Modificeret faktor vii/viia, dna-sekvens, som koder herfor, ekspressionsvektor indeholdende en saadan dna-sekvens, celle, der er transformeret med en saadan vektor og fremgangsmaade til fremstilling af modificeret faktor vii/viia
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ES8801674A1 (es) Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
DE69533556D1 (de) N-terminal modifizierte Polypeptide, und Herstellungsprozess
HUT52488A (en) Process for producing amino-acid-n-carboxy-anhydrides protected with urethane groups
IL85020A (en) Pancreatic secretory trypsin inhibitor variants, their production, expression vectors and recombinant hosts therefor and pharmaceutical compositions containing them
HUT40145A (en) Process for producing polypeptides and pharmaceutical compositions containing them
AU7008887A (en) Novel human tissue-type plasminogen activator polypeptides
IL76107A (en) Method of removing n-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby
FR2638643B1 (fr) Sequence d'adn codant pour le facteur ix humain ou une proteine analogue, vecteur d'expression, cellules transformees, procede de preparation du facteur ix et produits obtenus correspondants
IL100163A0 (en) Polypeptides,useful as plasminogen activators,plasmids coding therefor and their manufacture
DE3462039D1 (en) Peptide derivatives, their preparation and use as elastase inhibitors
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
GB8906156D0 (en) Production and use of anthelmintic agents and protective immunogens
AU575331B2 (en) Improved e. coli plasmid containing modified 5' cipoprotein sequence
NZ215994A (en) Culturing e.coli to produce interferon alpha and gamma and interleukin-2
DE3855751D1 (en) Hypoglycemische peptide
TW243453B (en) Cloning and characterization of a cardiac adenylyl cyclase
MX9709846A (es) Secuencias de acidos nucleico y aminoacidos relacionados con el helicobacter pylori para procedimientos de diagnostico y terapeuticos.